Faculty

Celia Stewart

Associate Professor of Communicative Sciences and Disorders

Celia Stewart

Phone: 998 5230
Email:

Professor Celia Stewart, an Associate Professor in the Department, earned her B.S. from Colorado State University, her M.S. from Phillips University, and her Ph.D. from New York University. She holds Clinical Certification from ASHA and licensure from New York State in Speech-Language Pathology. She has performed research at Mount Sinai Medical Center in the Department of Neurology and at the Columbia-Presbyterian Medical Center in the Department of Neurology. She has worked clinically in the Department of Neurology at Mount Sinai Medical Center, the Departments of Neurology and Speech and Hearing at New York Presbyterian Medical Center, the Communications Reconstruction Center in New York, the Community Speech and Hearing Center in Spartanburg, South Carolina, and the Teszler Learning Adjustment School in the Charles Lea Center in South Carolina. She is a member of the American Speech- Language and Hearing Association, New York State Speech-Language and Hearing Association, New York City Speech-Language and Hearing Association, International Society of Phonetic Sciences, ASHA Special Interest Divisions: Neurophysiology and Neurogenic Speech and Language Disorders, Voice and Voice Disorders, Swallowing and Swallowing Disorders. She is on the Steering Committee and WE MOVE Dystonia Task Force.


Degrees Held

  • B.S.
  • M.S.
  • Ph.D.

PUBLICATIONS

Original Peer-Reviewed Reports

1.    Aviv JE, Keen MS, Rodriguez HP, Stewart C, Gund E, & Blitzer A. Bilobed radial forearm free flap for functional reconstruction of near total glossectomy defects. Laryngoscope. 1994;104(7):893-900.

2.    Blitzer A, Brin MF, & Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients. Laryngoscope. 1998;108(10):1435-1441.

3.    Blitzer A, Brin MF, Stewart C, Aviv J, & Fahn S. Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope. 1992;102:163 167.

4.    Blitzer A, Komisar A, Baredes S, Brin M, & Stewart C. Voice failure after tracheoesophageal puncture: Management with botulinum toxin. Otolaryngology Head Neck Surgery. 1995;113:668-670.

5.    Braun N, Abd A, Baer J, Blitzer A, Stewart C, & Brin M. Dyspnea in dystonia: a functional evaluation. Chest. 1995;1309-1316.

6.    Brin MB, Stewart CF, Blitzer A, & Diamond B. Laryngeal botulinum toxin injections for disabling stuttering in adults. Neurology. 1994;44:2262-2266.

7.    de Leon D, Moskowitz CB, & Stewart CF. Proposed guidelines for videotaping individuals with movement disorders. Journal of Neuroscience Nursing. 1991;23:191 193.

8.    Salloway S, Morales X, Israeli L, Rasmussen S, Brin M, Stewart C, & Blitzer A. Botulinum toxin for refractory vocal tics. Movement Disorders. 1996;11:746-748.

9.    Stewart CF, Allen E, Tureen P, Diamond B, Blitzer, A., & Brin M. Evaluation of adductor spasmodic dysphonia. Journal of Voice. 1997;11(1):746-748.

10.    Stewart CF, Winfield L, Bressman S, Hunt A, & Brin M. Speech dysfunction in early Parkinson's disease. Movement Disorders. 1995;10(5):562-565.

11.    Sulica L, Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section. Ann Otol. Rhinol Laryngol, June 2003;112(6):499-505.

Chapters

1.    Blitzer A & Stewart CF. Abductor spasmodic dysphonia. In: J. Stemple (Ed.) Voice therapy: clinical studies. Mosby Year Book: Chicago. 1993:147-153.

2.    Blitzer A & Stewart CF. Management of abductor spasmodic dysphonia. In J.C. Stemple (Ed.) Voice Therapy: Clinical Studies. Singular Publishing Group, Inc: San Diego. 2010:400-406.

3.     Blitzer A & Stewart CF. Management of abductor spasmodic dysphonia. In J.C. Stemple and L.T. Fry (Eds.) Voice Therapy: Clinical Studies Third Edition. Singular Publishing Group, Inc: San Diego. 2010:4:00-406.

4.    Brin MF, Blitzer A, Herman S., & Stewart C. Oro facio mandibular and lingual dystonia (Meige syndrome): botulinum toxin treatment. In: J.P. Moore (Ed.) Handbook of botulinum toxin treatment. Blackwell Scientific, Oxford. 1995.

5.    Brin MF, Blitzer A, Herman S, & Stewart C. Oromandibular dystonia: treatment of 96 patients with botulinum toxin A. In: J. Jankovic & M. Hallett (Eds.) Botulinum toxin treatment. Marcel Decker, New York. 1994;429-435.

6.    Brin MF, Blitzer A, & Stewart C. Laryngeal dystonia (Spasmodic dysphonia): Observations of 901 patients and treatment with botulinum toxin. In S. Fahn, C. D. Marsden, & M. DeLong (Eds.), Dystonia 3 (Advances in neurology). Lippincott-Raven Publishers, Philadelphia, PA. 1998; 237-252.

7.    Brin MF, Blitzer A, & Stewart CF. Vocal tremor. In: L.J. Findley & W.C. Koller (Eds.) Handbook of Tremor Disorders. Marcel Decker, New York. 1995;495-520.

8.    Brin MF, Blitzer A, Stewart C, & Fahn S. Treatment of spasmodic dysphonia (laryngeal dystonia) with local injections of botulinum toxin: review and technical aspects. In: A. Blitzer, M.F. Brin, S. Fahn (Eds.) Neurological disorders of the larynx. Thieme, New York. 1992;214-228.

9.    Brin MF, Blitzer A, Stewart C, Pine ZM, Borg Stein J, Miller J, Viswanath NS, & Rosenfield DB. Disorders with excessive muscle contraction: candidates for treatment with intramuscular botulinum toxin (Botox). In: B.R. DasGupta (Ed.) Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects. Plenum, New York. 1992;559-576.

10.    Brin MF, Fahn S, Blitzer A, Ramig LO, & Stewart C. Movement disorders of the Larynx. In: A. Blitzer, M.F. Brin, & S. Fahn (Eds.) Neurological disorders of the larynx. Thieme, New York. 1992;248-278.

11.    Stewart CF. Practical approaches to managing speech and swallowing dystonia. In M. Brin, C. Camella, & J. Jankovic (Ed.) Dystonia Monograph; We Move 2003;65-69.

12.    Stewart CF. Intervention planning for adults with aphasia and related language disorders. In H.B. Klein & N. Moses (Eds.) Intervention planning II: Adults with communication problems. Allyn & Bacon: Needham Heights, MA. 1999;189- 270.

13.    Stewart CF and Allen EA. Voice therapy for unilateral vocal fold paralysis. In L. Sulica & A Blitzer (Eds.) Vocal Fold Paralysis. New York: Springer-Verlag. 2006;87-96.

14.     Stewart CF & Blitzer A. Management of abductor spasmodic dysphonia and Oral Mandibular Dystonia. In J.C. Stemple and L.T. Fry (Eds.) Voice Therapy: Clinical Studies, Third Edition. Singular Publishing Group, Inc: San Diego. 2010:386-399.

15.    Stewart CF, Blitzer A, & Brin M. Evaluation and management of swallowing and voice disorders. In D.S. Younger, (Ed.), Motor Disorders. Lippincott Williams & Wilkins: Philadelphia. 1999;477-491.

16.    Stewart CF, Blitzer A, & Brin M. Evaluation and management of swallowing and voice disorders. In D.S. Younger, (Ed.), Motor Disorders. Lippincott Williams & Wilkins: Philadelphia. 2007.

17.     Stewart CF, Blitzer A & Salloway S. Botulinum toxin treatment for a patient with Tourette’s syndrome. In J.C. Stemple (Ed.) Voice Therapy: Clinical Studies. Singular Publishing Group, Inc: San Diego. 2000;487-491.

18.    Stewart CF, Blitzer A & Salloway S. Botulinum toxin treatment for a patient with Tourette’s syndrome. In J.C. Stemple and L.T. Fry (Eds.). Voice Therapy: Clinical Studies 3rd Edition. Singular Publishing Group, Inc: San Diego. 2010;407-410.

19.    Stewart CF, Brin MF, & Blitzer A. Spasmodic dysphonia. In C.T. Ferrand and R.L. Bloom (Eds.). Introduction to organic and neurogenic disorders of communication. Allyn and Bacon: Boston, MA. 1997;301-318.

20.     Stewart CF & Riedel K. Managing speech and language deficits after stroke. In G.Gillen (Ed.) Stroke Rehabilitation: A Function Based Approach 3rd Edition. Elsevier/Mosby. (In press)

21.     Stewart CF, Song P, & Blitzer A. Diagnosis and management of dysphagia. In M. Fried & A. Ferlito (Eds.) The Larynx. San Diego: Pleural Publishing. 2008.

Awards

  • 2001 : Dystonia President's Award
  • 1999 : New York State Distinguished Clinician Award
  • 1997 : School of Education Goddard Faculty Fellowship Award
  • 1997 : NYU Service Award

Courses

  • CSCD-GE 2016 - Motor Speech Disorders
  • CSCD-GE 2037 - Voice Disorders
  • CSCD-GE 2019 - Therapeutic Approaches in Speech Pathology: Voice Disorders
  • CSCD-GE 2060 - Dysphagia
  • CSCD-GE 2041 - Advanced Anatomy and Physiology

Research Interests

  • Voice and Voice Disorders;
  • Neurogenic Communicative Disorders;
  • Dysphagia